Factors associated with overall and attributable mortality in invasive aspergillosis.
暂无分享,去创建一个
Philippe Lutun | Bruno Lioure | Karin Bilger | Raoul Herbrecht | J. Bergerat | P. Lutun | M. Velten | R. Herbrecht | V. Letscher-Bru | C. Fohrer | Y. Nivoix | Yasmine Nivoix | Michel Velten | Valérie Letscher-Bru | Alireza Moghaddam | Shanti Natarajan-Amé | Cécile Fohrer | Luc Marcellin | Anne Launoy | Guy Freys | Jean-Pierre Bergerat | B. Lioure | L. Marcellin | K. Bilger | G. Freys | A. Launoy | A. Moghaddam | S. Natarajan‐Amé
[1] Raoul Herbrecht,et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Gallamini,et al. False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment , 2004, Journal of Clinical Microbiology.
[3] M. Boeckh,et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.
[4] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[5] Lawrence Corey,et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] A. Venot,et al. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. , 1993, Leukemia & lymphoma.
[7] K. Rothman. Estimation of confidence limits for the cumulative probability of survival in life table analysis. , 1978, Journal of chronic diseases.
[8] F. Colardyn,et al. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. , 2004, The Journal of hospital infection.
[9] M. Pike,et al. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. , 1973, Biometrics.
[10] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[11] C. Cordonnier,et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] F. Lampe,et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] S J Lin,et al. Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Boeckh,et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] E. Jantunen,et al. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients , 2000, Bone Marrow Transplantation.
[16] T. Franquet,et al. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. , 2002, Haematologica.
[17] M. Maris,et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. , 2003, Blood.
[18] A. Humar,et al. American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] L. Pagano,et al. Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. , 1997, Journal of Infection.
[20] A. Sulahian,et al. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. , 2003, The New England journal of medicine.
[21] K. Rabe,et al. Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist , 2004, European Radiology.
[22] A. Bernard,et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Latgé,et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] R Sylvester,et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.
[25] J. Bergerat,et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] D. Denning,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] William R. Kirkpatrick,et al. Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.
[28] C. Heussel,et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] S. Balajee,et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. , 2004, The Journal of infectious diseases.